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Introduction: Aboriginal Australians have a substantially higher frequency of ischaemic heart disease (IHD) events
than their non-Aboriginal counterparts, together with a higher prevalence of comorbidities. The pattern of health
service provision for IHD suggests inequitable delivery of important diagnostic procedures. Published data on
disparities in IHD management among Aboriginal Australians are conflicting, and the role of comorbidities has
not been adequately delineated. We compared the profiles of Aboriginal and non-Aboriginal patients in the
metropolitan area undergoing emergency IHD admissions at Western Australian metropolitan hospitals, and
investigated the determinants of receiving coronary angiography.
Methods: Person-linked administrative hospital and mortality records were used to identify 28-day survivors of IHD
emergency admission events (n =20,816) commencing at metropolitan hospitals in 2005–09. The outcome measure
was receipt of angiography. The Aboriginal to non-Aboriginal risk ratio (RR) was estimated from a multivariable
Poisson log-linear regression model with allowance for multiple IHD events in individuals. The subgroup of
myocardial infarction (MI) events was modelled separately.
Results: Compared with their non-Aboriginal counterparts, Aboriginal IHD patients were younger and more likely
to have comorbidities. In the age- and sex-adjusted model, Aboriginal patients were less likely than others to
receive angiography (RRIHD 0.77, 95% CI 0.72-0.83; RRMI 0.81, 95% CI 0.75-0.87) but in the full multivariable model this
disparity was accounted for by comorbidities as well as IHD category and MI subtype, and private health insurance
(RRIHD 0.95, 95% CI 0.89-1.01; RRMI 0.94, 95% CI 0.88-1.01). When stratified by age groups, this disparity was not
significant in the 25–54 year age group (RRMI 0.95, 95% CI 0.88-1.02) but was significant in the 55–84 year age group
(RRMI 0.88, 95% CI 0.77-0.99).
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Conclusions: The disproportionate under-management of older Aboriginal IHD patients is of particular concern.
Regardless of age, the disparity between Aboriginal and non-Aboriginal Australians in receiving angiography for
acute IHD in a metropolitan setting is mediated substantially by comorbidities. This constellation of health problems
is a ‘double-whammy’ for Aboriginal people, predisposing them to IHD and also adversely impacting on their
receipt of angiography. Further research should investigate how older age and comorbidities influence clinical
decision making in this context.
Keywords: Aboriginal, Oceanic ancestry group, Australia, Ischaemic heart disease, Myocardial infarction, Healthcare
Disparities, Hospitals, urban, Coronary angiography, Age factors, ComorbidityIntroduction
Ischaemic heart disease (IHD) is the highest ranking con-
tributor to the substantial life expectancy gap between
Aboriginal and non-Aboriginal populations in Australia
[1]. Coupled with this, Aboriginal Australians with IHD
are known to have a higher prevalence of several major
comorbid conditions that adversely influence outcomes
[2] and may diminish the likelihood of receiving coronary
angiography [3]. Coronary angiography is an integral com-
ponent of guideline-adherent care for acute IHD and an
essential precursor to a coronary artery revascularisation
procedure (CARP). Disparity between Aboriginal and
non-Aboriginal patients in receiving a CARP following
acute admission for IHD has been explored in a several
large cohort studies, with inconsistent findings [4-7].
This aim of this administrative linked data study was
to investigate disparities in provision of coronary angiog-
raphy to Aboriginal and non-Aboriginal IHD patients
undergoing emergency admissions to metropolitan hos-
pitals in Western Australia (WA). WA’s only metropol-
itan area (encompassing the capital city, Perth) had a
population of around 1.6 million in 2011, of whom ap-
proximately 1.6% identify as Aboriginal [8]. The out-
come examined was coronary angiography rather than
CARP per se, as provision of CARP is dependent on pa-
tients’ angiographic findings, information which is not
available from administrative records. We have previ-
ously reported on the rural population [9] and in this
current paper we considered only the metropolitan
population, as their pathways to receiving coronary diag-
nostic and intervention procedures are different from
those of non-metropolitan patients. In WA, IHD pa-
tients from outside the metropolitan area require trans-
fer to a cardiac catheterisation-capable hospital, the
determinants of which can be complex [9-11]. There is
also a complex relationship between age, sex, Aboriginal
status, geographical residence (metropolitan, regional,
very remote) and the incidence of myocardial infarction
(MI), with non-metropolitan people not uniformly disad-
vantaged [12]. Compared with metropolitan people, re-
gional Aboriginal men and very remote non-Aboriginal
men aged 25–54 years have significantly higher incidencerates of MI. Furthermore, this paper addresses the
sparse data about the health of Aboriginal people who
live in metropolitan areas [13]. We separately analysed
the subgroup of patients with MI, allowing investigation
of a relatively homogeneous group for which diagnostic
categorisation in administrative data is relatively accur-
ate and for which there are well-defined evidence-based
clinical guidelines for diagnosis and therapy.Methods
Data source
A person-linked file of all metropolitan residents admitted
to metropolitan hospitals from 2005 to 2009 with a princi-
pal discharge diagnostic code of IHD, incorporating their
previous (15-year history) and subsequent hospital admis-
sions, was extracted from the Hospital Morbidity Data
Collection (HMDC) and Deaths datasets of the Western
Australian Data Linkage System (WADLS). The WADLS
is a comprehensive system linking population-based ad-
ministrative health data from several statutory datasets
through probabilistic matching, with the proportions of
invalid (false positives) or missed links (false negatives)
both estimated at 0.1% of matches [14].Study cohort
We identified IHD events in metropolitan residents aged
25–84 years who were admitted to metropolitan public
and private hospitals from 2005 to 2009 (Figure 1). The
starting point of an episode (defined as a series of con-
tiguous hospital admissions, including inter-hospital
transfers) was an emergency admission to a metropolitan
hospital with a principal discharge diagnosis of IHD. An
event included all admissions (booked or emergency)
associated with the initial episode of care and any
additional episodes starting within a 28-day period fol-
lowing the initial emergency admission. Any subsequent
emergency IHD admission to metropolitan hospitals out-
side this event definition was considered a new event.
Thus, a person could have multiple events over the study
period. Events followed by death within 28 days were

























Figure 1 Flow diagram of IHD and MI events from 2005–09 in metropolitan WA by Aboriginal status. IHD = ischaemic heart disease;
MI = myocardial infarction.
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comparing outcomes with and without the 28-day deaths.
For each event, patient demographic variables and 15-
year admission histories of specified comorbidities (chronic
pulmonary disease, diabetes, heart failure [HF], kidney dis-
ease and pre-existing IHD) were recorded. Comorbidities
were identified using International Classification of Diseases
Australian Modification 10th revision (ICD-10-AM) codes
defined by Quan et al. [15]. These comorbidities were se-
lected as they are associated with increased risk of compli-
cations with coronary procedures [16,17]. The accuracy of
identifying diabetes and HF in these datasets has been re-
ported previously and can be improved by extending the
hospitalisation look-back [18,19]. Sensitivity analyses were
performed using comorbidities based on 1-, 2-, 5- and 10-
year look-back periods. IHD category was classified as MI
(ICD-10-AM: I21), unstable angina (I20.0) or other IHD
(all other ICD codes between I20-I25) in the principal
diagnosis field. MI subtype was categorised in line with
ICD codes, namely transmural (I21.0-I21.3), subendocar-
dial (I21.4) or other (I21.9), rather than by guidelines
based on the presence or absence of electrocardiographic
ST elevation. Socio-Economic Indexes for Areas (SEIFA)
Index of Relative Socio-Economic Disadvantage scores
categorised by quartiles were used as a measure of socio-
economic status (SES) [20]. SEIFA scores are generalpopulation area-based measures of SES derived for each
census Collection District (about 225 dwellings) [21]. For
all events, SEIFA scores for a more aggregated geograph-
ical level (i.e. Statistical Local Area of residence) were used
as some patients did not have a score at the Collection
District level. As Aboriginal status is known to be under-
reported in administrative health data [22,23], any patient
identified as Aboriginal and/or Torres Strait Islander on
any hospital admission since 1980 in the HMDC was clas-
sified as Aboriginal. Sensitivity analyses were performed
for Aboriginal status based on (i) identification in at least
25% of hospital admissions (HMDC) and, (ii) identifica-
tion at the initial admission for the event. Private health
insurance status was defined as having private insurance
at any admission during the event, as recorded in the
HMDC. Australia has a publicly-funded universal health-
care system that aims to provide all Australians, regardless
of personal circumstances, access to adequate care at an
affordable or no cost to the individual. This is supported
by optional private health insurance for hospital treatment
as a private patient and for ancillary health services (e.g.
physiotherapy) provided outside a hospital.
Study outcomes
The outcome examined was coronary angiography. For
each event, we determined if the patient received coronary
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tions Block 668) within 28 days of the event admission
date. Angiography was also assumed to have been per-
formed if the patient had a CARP (Blocks 669–679) re-
corded within 28 days of the event admission date where
angiography was not separately recorded in the procedure
fields. Sensitivity analyses were performed comparing out-
comes (receipt of coronary angiography among those sur-
viving) for events defined by a 90-day instead of a 28-day
interval, in order to investigate the effects of unexpected
delays in cardiac catheterisation.
Statistical analyses
Analyses were performed using SAS 9.4 (SAS Institute).
Baseline demographic and comorbidity characteristics of
events involving Aboriginal and non-Aboriginal subjects
were summarised separately. Chi-square tests were used
to test for significance of categorical variables. To model
event-based receipt of coronary angiography allowing for
multiple events in each patient, a Poisson distribution for
the dependent variable, together with a log link function,
exchangeable variance structure across multiple events for
a patient, maximum-likelihood method and robust stand-
ard errors was used. When the outcome is binary, the
exponentiated coefficients from the Poisson regression
represent risk ratios (RR) rather than incidence-rate ratios
and the robust standard errors take into account both the
use of the Poisson model as a working model for binary
data and the clustering of events within individuals [24]. In
addition to an unadjusted model that included Aboriginal
status only, six models with sequential addition of vari-
ables were developed: Model 1 (10-year age categories and
sex); Model 2 (Model 1 + SES); Model 3 (Model 2 + private
health insurance); Model 4 (Model 3 + IHD category/MI
subtype and coronary angiography in the last year); Model
5 versions a-e (Model 4 + individual comorbidities); and
Model 6 (Model 4 + all comorbidities combined). Al-
though data on type of hospital (tertiary, other public, pri-
vate) were available in the HMDS, we did not include the
hospital type at initial admission in the full model given
the complex determinants of hospital of initial admission
for acute IHD; this includes results of pre-hospital (ambu-
lance-based) electrocardiographic testing [25], time of day,
and traffic conditions. Furthermore, metropolitan IHD pa-
tients are commonly transferred between hospitals for
treatment. Sensitivity analysis based on hospital type at ini-
tial admission is presented. Previous work from our group
has identified different age and sex distribution of incident
MI cases in Aboriginal and non-Aboriginal people [26].
Accordingly, interactions between Aboriginal status*age
and Aboriginal status*sex were investigated. In whole co-
hort analyses age was modelled using 10-year age categor-
ies but in the broad age group specific analyses (25–54
and 55–84 years) age was modelled using age and age*age.Ethics
Ethics approval was obtained from Human Research Ethics
Committees of WA Aboriginal Health, The University of
Western Australia and WA Department of Health.
Results
Event characteristics
Of the 21,433 IHD events identified in metropolitan hospi-
tals from 2005 to 2009 (Figure 1), 20,816 (97.1%) resulted in
survival to 28 days. Aboriginal patients accounted for 3.9%
of events. A significantly lower proportion of Aboriginal
than non-Aboriginal patients with IHD (50.2% vs 61.1%,
p<0.001) and MI (69.6% vs 78.8%, p<0.001) received coron-
ary angiography.
As shown in Table 1 (events-based characteristics) and
Table 2 (person-based characteristics), Aboriginal patients
admitted for IHD or MI events were significantly younger
and more likely than their non-Aboriginal patients to be fe-
male, have lower SES and have comorbidities (pre-existing
IHD, chronic pulmonary disease, diabetes, HF and kidney
disease), but less likely to have private health insurance.
Aboriginal patients had more events per person than non-
Aboriginal: 25.5% vs 15.8% (p<0.001) respectively had two
or more events (Table 2).
Aboriginal disparity in receipt of coronary angiography
After adjusting for age and sex, Aboriginal people with
IHD were 23% less likely than non-Aboriginal people to
receive coronary angiography (Model 1: RRIHD 0.77, 95%
CI 0.72-0.83) (Table 3). This disparity was diminished after
progressive adjustments for SES (Model 2: RRIHD 0.80,
95% CI 0.75-0.86), private health insurance (Model 3:
RRIHD 0.84, 95% CI 0.79-0.90) and IHD category and cor-
onary angiography in the last year (Model 4: RRIHD 0.87,
95% CI 0.82-0.93). Adjustment for individual comorbidi-
ties (Models 5a-e), especially HF (Model 5d: RRIHD 0.91,
95% CI 0.86-0.97) and kidney disease (Model 5e: RRIHD
0.91, 95% CI 0.85-0.97) substantially reduced the gap to
9% less likely. The disparity was not significant in the full
model (Model 6: RRIHD 0.95, 95% CI 0.89-1.01) which in-
cluded all five comorbidities together. A similar pattern of
reduction in the investigation gap was seen in the MI pa-
tient subgroup (Table 3). Much of the disparity was ex-
plained by comorbidities, especially kidney disease (Model
5e: RRMI 0.91, 95% CI 0.85-0.97). There was no statistically
significant difference in receipt of coronary angiography
between Aboriginal and non-Aboriginal patients in the full
model (Model 6: RRMI 0.94, 95% CI 0.88-1.01).
A significant interaction was found for Aboriginal*age
(p<0.05). Even when stratified by two age groups (25–54
years and 55–84 years), comorbidities accounted for much
of the disparity in receiving coronary angiography (Model
4a versus 6a) (Table 3). Disparity between Aboriginal and
non-Aboriginal events in the fully-adjusted model remained
Table 1 Demographic and clinical profile of IHD and MI events originating from WA metropolitan hospitals
All IHD (n = 20,816 events) MI only (n = 8,772 events)
Aboriginal Non-Aboriginal p value Aboriginal Non-Aboriginal p value
n = 817 events for
552 patients
n = 19,999 events for
16,091 patients
n = 309 events for
253 patients
n = 8,463 events for
7,880 patients
Age groups <0.001 <0.001
25-34 years 17 (2.1) 85 (0.4) 7 (2.3) 46 (0.5)
35-44 years 151 (18.5) 837 (4.2) 71 (23.0) 412 (4.9)
45-54 years 257 (31.5) 2,798 (14.0) 94 (30.4) 1,273 (15.0)
55-64 years 227 (27.8) 4,822 (24.1) 75 (24.3) 2,071 (24.5)
65-74 years 127 (15.5) 5,235 (26.2) 44 (14.2) 2,091 (24.7)
75-84 years 38 (4.7) 6,222 (31.1) 18 (5.8) 2,570 (30.4)
Sex: Female 381 (46.6) 6,976 (34.9) <0.001 129 (41.7) 2,532 (29.9) <0.001
SES quartiles <0.001 <0.001
1st quartile(a) 436 (53.4) 5,240 (26.2) 161 (52.1) 2,015 (23.8)
2nd quartile 244 (29.9) 6,017 (30.1) 83 (26.9) 2,565 (30.3)
3rd quartile 95 (11.6) 4,488 (22.4) 46 (14.9) 1,933 (22.8)
4th quartile(b) 42 (5.1) 4,254 (21.3) 19 (6.1) 1,950 (23.0)
Comorbidities
Pre-existing IHD(c) 499 (61.1) 9,237 (46.2) <0.001 146 (47.2) 2,487 (29.4) <0.001
Chronic pulmonary
disease
192 (23.5) 2,926 (14.6) <0.001 58 (18.8) 1,036 (12.2) 0.001
Diabetes 463 (56.7) 5,790 (29.0) <0.001 173 (56.0) 2,369 (28.0) <0.001
HF 241 (29.5) 3,768 (18.4) <0.001 101 (32.7) 1,767 (20.9) <0.001
Kidney disease 180 (22.0) 2,144 (10.7) <0.001 80 (25.9) 950 (11.2) <0.001
Coronary angiography in
the last year
134 (16.4) 2,447 (12.2) <0.001 34 (11.0) 431 (5.1) <0.001
Private health insurance (%) 61 (7.5) 7,277 (36.4) <0.001 23 (7.4) 3,186 (37.6) <0.001
IHD category (%) 0.04
MI 309 (37.8) 8,463 (42.3)
Unstable angina 315 (38.6) 7,042 (35.2)
Other IHD 193 (23.6) 4,494 (22.5)
MI subtype 0.08
Transmural 87 (28.2) 2,792 (33.0)
Subendocardial/other 222 (71.8) 5,671 (67.0)
Hospital at initial admission <0.001 <0.001
Metropolitan tertiary 637 (78.0) 12,992 (65.0) 264 (85.4) 6,292 (74.3)
Metropolitan non-tertiary(d) 103 (12.6) 1,678 (8.4) 11 (3.6) 237 (2.8)
Private 77 (9.4) 5,329 (26.6) 34 (11.0) 1,934 (22.9)
Statistical significance determined using chi-square tests. HF = heart failure; IHD = ischaemic heart disease; MI = myocardial infarction; SES = socio-economic status.
(a)most disadvantaged; (b)least disadvantaged; (c)excluding incident IHD; (d)excluding private hospitals.
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for both IHD (Model 6a: RRIHD 0.87, 95% CI 0.79-0.97)
and MI (Model 6a: RRMI 0.88, 95% CI 0.77-0.99) but not
for either in the younger age group (25–54 years). As previ-
ous events and prior angiography may influence receipt of
this procedure in future events, analyses were repeated with
restriction to (i) first event only and (ii) events without priorangiography in the previous year, producing similar results
for both all IHD and MI (Table 3).
Individual characteristics associated with outcomes
In the full multivariable model for MI events, factors in-
dependently associated with a lower likelihood of receiv-
ing coronary angiography in the whole cohort were
Table 2 Demographic and clinical profile of IHD and MI patients at their first event
All IHD (n = 16,643 patients) MI only (n = 8,133 patients)
Aboriginal Non-Aboriginal p value Aboriginal Non-Aboriginal p value
n = 552 patients n = 16,091 patients n = 253 patients n = 7,880 patients
Number of events <0.001 <0.001
1 411 (74.5) 13,542 (84.2) 209 (82.6) 7,399 (93.9)
2 84 (15.2) 1,822 (11.3) 32 (12.6) 399 (5.1)
>2 57 (10.3) 727 (4.5) 12 (4.7) 82 (1.0)
Age groups <0.001 <0.001
25-34 years 16 (2.9) 79 (0.5) 7 (2.8) 46 (0.6)
35-44 years 113 (20.5) 754 (4.7) 60 (23.7) 404 (5.1)
45-54 years 155 (28.1) 2,377 (14.8) 70 (27.7) 1,222 (15.5)
55-64 years 155 (28.1) 4,019 (25.0) 64 (25.3) 1,970 (25.0)
65-74 years 81 (14.7) 4,219 (26.2) 35 (13.8) 1,962 (24.9)
75-84 years 32 (5.8) 4,643 (28.9) 17 (6.7) 2,276 (28.9)
Sex: Female 270 (48.9) 5,628 (35.0) <0.001 103 (40.7) 2,332 (29.6) <0.001
SES quartiles <0.001 <0.001
1st quartile(a) 289 (52.4) 4,000 (24.9) 129 (51.0) 1,845 (23.4)
2nd quartile 169 (30.6) 4,779 (29.7) 67 (26.5) 2,367 (30.0)
3rd quartile 62 (11.2) 3,651 (22.7) 40 (15.8) 1,807 (22.9)
4th quartile(b) 32 (5.8) 3,661 (22.8) 17 (6.7) 1,861 (23.6)
Coronary angiography in the last year 33 (6.0) 927 (5.8) 0.83 12 (4.7) 253 (3.2) 0.18
Comorbidities
Pre-existing IHD(c) 234 (42.4) 5,329 (33.1) <0.001 90 (35.6) 1,904 (24.2) <0.001
Chronic pulmonary disease 123 (22.3) 2,071 (12.9) <0.001 45 (17.8) 914 (11.6) 0.003
Diabetes 293 (53.1) 4,179 (26.0) <0.001 131 (51.8) 2,086 (26.5) <0.001
HF 131 (23.7) 2,461 (15.3) <0.001 72 (28.5) 1,465 (18.6) <0.001
Kidney disease 98 (17.8) 1,302 (8.1) <0.001 56 (22.1) 744 (9.4) <0.001
Hospital at initial admission <0.001 <0.001
Metropolitan tertiary 428 (77.5) 10,435 (64.8) 216 (85.4) 5,875 (74.6)
Metropolitan non-tertiary(d) 69 (12.5) 1,272 (7.9) 8 (3.2) 215 (2.7)
Private 55 (10.0) 4,384 (27.2) 29 (11.5) 1,790 (22.7)
Statistical significance determined using chi-square tests.
HF = heart failure; IHD = ischaemic heart disease; MI = myocardial infarction; SES = socio-economic status.
(a)most disadvantaged; (b)least disadvantaged; (c)excluding incident IHD; (d)excluding private hospitals.
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health insurance, having coronary angiography in the
previous year, and having chronic pulmonary disease,
HF or kidney disease, while having transmural MI was
associated with higher likelihood of receiving this pro-
cedure (Table 4). Factors in the younger group (25–54
years) associated with the likelihood of receiving angiog-
raphy were similar to the whole cohort except that being
female (RRMI 1.00, 95% CI 0.97-1.04) and having pre-
existing IHD (RRMI 1.00, 95% CI 0.93-1.07) were not
associated with a lower likelihood of receiving angiog-
raphy, whereas having diabetes was independently asso-
ciated with this outcome (RRMI 0.95, 95% CI 0.91-0.99).
In the older age group (55–84 years), apart from thelower likelihood of Aboriginal patients receiving angiog-
raphy, estimates for all variables were similar to those
for the whole cohort. SES was not independently associ-
ated with the outcome in either the whole cohort or the
two age-groups.
Sensitivity analyses
Table 5 shows the fully adjusted RRs (Model 6a) for (i)
two alternative definitions of Aboriginal status (Aboriginal
identification in at least 25% of hospital admissions or
at first hospital admission for the event), (ii) 90-day
events, (iii) different comorbidity look-back periods, (iv)
hospital type at initial admission, and (v) inclusion of
events where patients died within 28 days. The RRs for
Table 3 Comparison of Aboriginal and non-Aboriginal probabilities of receipt of angiogram following IHD and MI events
All IHD MI only
Aboriginal status = Yes Description of model RR (95% CI) p value RR (95% CI) p value
Progressive adjustment:
Unadjusted 0.84 (0.78-0.90) <0.0001 0.90 (0.83-0.96) <0.01
Model 1 Age categories, sex 0.77 (0.72-0.83) <0.0001 0.81 (0.75-0.87) <0.0001
Model 2 Model 1 + SES 0.80 (0.75-0.86) <0.0001 0.82 (0.76-0.88) <0.0001
Model 3 Model 2 + private health insurance 0.84 (0.79-0.90) <0.0001 0.84 (0.78-0.90) <0.0001
Model 4 Model 3 + IHD category/MI subtype and
angiography in the last year
0.87 (0.82-0.93) <0.0001 0.86 (0.80-0.92) <0.0001
Model 5 (comorbidities):
Model 5a Model 4 + pre-existing IHD 0.89 (0.84-0.95) <0.001 0.88 (0.82-0.94) <0.001
Model 5b Model 4 + chronic pulmonary disease 0.89 (0.83-0.95) <0.001 0.87 (0.81-0.94) <0.001
Model 5c Model 4 + diabetes 0.89 (0.83-0.95) <0.001 0.88 (0.82-0.94) <0.01
Model 5d Model 4 + HF 0.91 (0.86-0.97) <0.01 0.90 (0.84-0.97) <0.01
Model 5e Model 4 + kidney disease 0.91 (0.85-0.97) <0.01 0.91 (0.85-0.97) <0.01
Model 6 Model 4 + all five comorbidities (i.e. full model) 0.95 (0.89-1.01) 0.10 0.94 (0.88-1.01) 0.08
Stratified by age(a)
Aged 25–54 years:
Model 1a Model 1 but with age and age*age 0.83 (0.76-0.90) <0.0001 0.85 (0.79-0.92) <0.0001
Model 4a Model 4 but with age and age*age 0.91 (0.85-0.99) 0.03 0.88 (0.82-0.95) <0.001
Model 6a Model 6 but with age and age*age 0.96 (0.89-1.04) 0.36 0.95 (0.88-1.02) 0.16
Aged 55–84 years:
Model 1a Model 1 but with age and age*age 0.70 (0.63-0.79) <0.0001 0.73 (0.63-0.84) <0.0001
Model 4a Model 4 but with age and age*age 0.78 (0.70-0.87) <0.0001 0.79 (0.69-0.91) <0.001
Model 6a Model 6 but with age and age*age 0.87 (0.79-0.97) 0.01 0.88 (0.77-0.99) 0.04
Restricted to first event(a)
Aged 25–54 years:
Model 4a Model 4 but with age and age*age 0.93 (0.85-1.01) 0.09 0.89 (0.83-0.97) <0.01
Model 6a Model 6 but with age and age*age 0.97 (0.89-1.05) 0.43 0.95 (0.88-1.02) 0.14
Aged 55–84 years:
Model 4a Model 4 but with age and age*age 0.80 (0.72-0.90) <0.001 0.79 (0.69-0.91) <0.001
Model 6a Model 6 but with age and age*age 0.88 (0.79-0.99) 0.03 0.87 (0.77-0.99) 0.04
Restricted to events without angiography in the previous year(a)
Aged 25–54 years:
Model 4a Model 4 but with age and age*age 0.92 (0.85-0.99) 0.04 (b)
Model 6a Model 6 but with age and age*age 0.97 (0.89-1.04) 0.38 (b)
Aged 55–84 years:
Model 4a Model 4 but with age and age*age 0.80 (0.72-0.89) <0.0001 0.79 (0.69-0.91) 0.001
Model 6a Model 6 but with age and age*age 0.88 (0.80-0.98) 0.02 0.88 (0.77-1.00) 0.05
Reference group is non-Aboriginal patients.
RR = risk ratio with reference group being non-Aboriginal patients; 95% CI = 95% confidence interval; HF = heart failure; IHD = ischaemic heart disease;
MI = myocardial infarction; SES = socio-economic status.
(a)Models use age and age*age rather than age categories; (b)unable to estimate.
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status in these analyses were very similar to those based
on the original definitions of Aboriginal status, eventduration, comorbidity look-back period, models that ex-
clude hospital type and models that exclude events where
patients died within 28 days.
Table 4 Independent predictors for receipt of coronary angiography in MI events
Receipt of coronary angiography in MI events
Whole cohort (n = 8,722
events)
Aged 25–54 years (n = 1,903
events)
Aged 55–84 years (n = 6,869
events)
RR (95% CI) p value RR (95% CI) p value RR (95% CI) p value
Aboriginal 0.94 (0.88-1.01) 0.08 0.95 (0.88-1.02) 0.16 0.88 (0.77-0.99) 0.04
Age groups
25-34 years 1.01 (0.94-1.07) 0.87
35-44 years 1.02 (0.99-1.04) 0.19
45-54 years 1
55-64 years 1.00 (0.98-1.02) 0.87
65-74 years 0.97 (0.95-0.99) 0.01
75-84 years 0.73 (0.71-0.76) <0.0001
Age 1.01 (0.98-1.03) 0.16 1.20 (1.17-1.24) <0.0001
Age*age 1.00 (0.99-1.00) 0.51 0.99 (0.99-0.99) <0.0001
Sex: Female 0.94 (0.92-0.96) <0.0001 1.00 (0.97-1.04) 0.90 0.94 (0.91-0.96) <0.0001
SES quartiles
1st quartile(a) 1 1 1
2nd quartile 1.01 (0.98-1.04) 0.44 0.99 (0.95-1.03) 0.50 1.02 (0.98-1.05) 0.37
3rd quartile 1.00 (0.97-1.03) 0.83 0.99 (0.95-1.04) 0.74 1.00 (0.96-1.04) 0.99
4th quartile(b) 0.99 (0.97-1.02) 0.70 1.00 (0.96-1.04) 0.95 0.99 (0.95-1.03) 0.54
No private health insurance 0.92 (0.90-0.93) <0.01 0.97 (0.95-0.99) 0.01 0.91 (0.88-0.93) <0.01
MI subtype(c)
Transmural 1.10 (1.09-1.12) <0.0001 1.04 (1.01-1.07) <0.01 1.12 (1.10-1.15) <0.0001
Subendocardial/other 1 1 1
Coronary angiography in the previous year 0.74 (0.67-0.81) <0.0001 0.77 (0.64-0.92) <0.01 0.73 (0.66-0.82) <0.0001
Pre-existing IHD(d) 0.95 (0.92-0.98) <0.01 1.00 (0.93-1.07) 0.99 0.95 (0.92-0.99) <0.01
Chronic pulmonary disease 0.89 (0.85-0.93) <0.0001 0.85 (0.73-0.97) 0.02 0.89 (0.85-0.94) <0.0001
Diabetes 0.99 (0.97-1.02) 0.51 0.95 (0.91-0.99) 0.01 1.00 (0.97-1.03) 0.78
HF 0.75 (0.72-0.79) <0.0001 0.88 (0.80-0.97) <0.01 0.75 (0.71-0.79) <0.0001
Kidney disease 0.78 (0.73-0.81) <0.0001 0.71 (0.57-0.89) <0.01 0.79 (0.74-0.85) <0.0001
(a)most disadvantaged; (b)least disadvantaged; (c)MI subtype was based on ICD-10-AM coding terminology; (d)excluding incident IHD.
RR = Risk ratio; 95% CI = 95% confidence interval; IHD = ischaemic heart disease; HF = heart failure; MI = myocardial infarction; SES = socio-economic status.
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This study expands on other Australian research [4-7]
investigating Aboriginal disparities in receipt of coronary
angiography by restricting the analysis to metropolitan
patients, and contributes to the sparse data on the health
of Aboriginal people who live in metropolitan areas [13].
In this study of 20,816 acute IHD events (average 11
events/day) in metropolitan WA from 2005 to 2009, the
distinctive demographic characteristics (younger, greater
female representation, less likely to have private health
insurance), higher prevalence of comorbidities and over-
representation of Aboriginal patients were consistent with
those reported previously [4,5,7,27]. When the differing
socio-demographic and clinical profiles were taken into
account by multivariate adjustment, a reduced likelihood
of Aboriginal people receiving coronary angiography incomparison with non-Aboriginal people was only evident
among older patients (aged 55–84 years). Higher comor-
bidities among Aboriginal people contributed substantially
to the outcome disparities. The disparities for all IHD
events and the MI subgroup were similar, so our discus-
sion generally focuses on MI events unless comparison is
made to other reported IHD findings.
The proportion of MI patients receiving coronary
angiography in our study is slightly higher than that doc-
umented in the 2012 SNAPSHOT ACS study (78% vs
71%) conducted throughout Australia and New Zealand
[28] and those of Randall et al. in New South Wales,
Australia [5]. This likely reflects our more stringent case
selection (MI in principal diagnosis field only) and our
exclusive metropolitan focus. In our full multivariable
model, the findings that older people, women and those
Table 5 Sensitivity analyses using different Aboriginal identification definitions, 90-day events, comorbidity look-back
periods, hospital type and 28-day deaths
All IHD MI only
Multivariate adjusted likelihood of
Aboriginal patients receiving
angiography
Aged 25–54 years Aged 55–84 years Aged 25–54 years Aged 55–84 years
RR (95% CI) p value RR (95% CI) p value RR (95% CI) p value RR (95% CI) p value
(i) Definition of Aboriginal identification
Any admission* 0.96 (0.89-1.04) 0.36 0.87 (0.79-0.97) 0.01 0.95 (0.88-1.02) 0.16 0.88 (0.77-0.99) 0.04
≥25% of admissions 0.95 (0.88-1.04) 0.27 0.89 (0.79-1.00) 0.05 0.94 (0.87-1.02) 0.13 0.87 (0.76-1.01) 0.07
First admission for the event 0.96 (0.88-1.05) 0.33 0.90 (0.80-1.02) 0.09 0.93 (0.86-1.01) 0.10 0.87 (0.75-1.01) 0.08
(ii) Definition of event duration
28-day event (Aboriginal any admission)* 0.96 (0.89-1.04) 0.36 0.87 (0.79-0.97) 0.01 0.95 (0.88-1.02) 0.16 0.88 (0.77-0.99) 0.04
90-day event (Aboriginal any admission) 0.94 (0.87-1.01) 0.10 0.87 (0.79-0.96) <0.01 0.96 (0.89-1.02) 0.19 0.87 (0.77-0.98) 0.02
(iii) Different comorbidity look-back periods
1-year 0.95 (0.88-1.03) 0.18 0.84 (0.75-0.93) 0.001 0.94 (0.88-1.01) 0.12 0.86 (0.75-0.97) 0.002
2-year 0.96 (0.89-1.04) 0.29 0.85 (0.76-0.94) 0.002 0.95 (0.88-1.02) 0.17 0.86 (0.76-0.98) 0.02
5-year 0.96 (0.89-1.04) 0.35 0.86 (0.77-0.95) 0.003 0.95 (0.88-1.02) 0.17 0.87 (0.77-0.99) 0.03
10-year 0.96 (0.89-1.04) 0.36 0.86 (0.77-0.95) 0.003 0.95 (0.88-1.02) 0.14 0.87 (0.76-0.98) 0.03
15-year* 0.96 (0.89-1.04) 0.36 0.87 (0.79-0.97) 0.01 0.95 (0.88-1.02) 0.16 0.88 (0.77-0.99) 0.04
(iv) Model 6a + hospital type at initial
admission
0.96 (0.88-1.04) 0.31 0.88 (0.80-0.98) 0.02 0.95 (0.88-1.02) 0.15 0.88 (0.77-0.99) 0.04
(v) Model 6a with inclusion of events where
patients died within 28 days
0.97 (0.90-1.05) 0.46 0.88 (0.79-0.97) 0.01 0.96 (0.89-1.03) 0.25 0.88 (0.78-1.00) 0.06
For each sensitivity analysis, ‘*’ represents the original model (Model 6a from Table 3) which has been adjusted for age, age*age, sex, SES, private health insurance,
IHD category (for IHD)/MI subtype (for MI), coronary angiography performed in the last year, 15-year histories of IHD, chronic pulmonary disease, diabetes, HF and kidney
disease. Hospital type at initial admission is classified as metropolitan tertiary, metropolitan non-tertiary (excluding private hospital) or private. HF = heart failure;
IHD = ischaemic heart disease; MI =myocardial infarction; RR = risk ratio; 95% CI = 95% confidence interval.
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ceive coronary procedures are consistent with those of
previous studies [3,5,9,29,30]. SES was not associated
with receiving angiography which may reflect SEIFA be-
ing an ecological measure of SES.
In relation to Aboriginal status, the results of our full
model are consistent with Randall’s study [5], in which dis-
parity in receiving coronary angiography was found for
Aboriginal versus non-Aboriginal people after adjustment
for age, sex, admission year, MI subtype and admitting hos-
pital (adjusted hazard ratio [AHR] 0.81, 95% CI 0.74-0.88),
and was largely explained by the higher burden of comor-
bidities, substance abuse and private health insurance
among Aboriginal people (AHR 0.94, 95% CI 0.87-1.03).
Randall found similar results for CARP (coronary angiog-
raphy is a precursor to CARP), in that there was a large dis-
parity between Aboriginal and non-Aboriginal people after
adjusting for age, sex, year and MI subtype (AHR 0.63, 95%
CI 0.57-0.70) and no significant disparity remaining after
adjusting for hospital of admission, comorbidities, sub-
stance abuse and private health insurance (AHR 0.96, 95%
CI 0.87-1.07) [5]. Similarly, a WA study using the Perth
Aboriginal Atherosclerosis Risk Study cohort of metropol-
itan Aboriginal people found that CARPs for IHD wereprovided with equal frequency for Aboriginal people and
age- and sex-matched non-Aboriginal people [31].
As there was an interaction between Aboriginal status
and age, we modelled age by dichotomous stratification
concomitantly with multivariate adjustment by age and
age-squared as continuous variables. In doing so, we added
to the findings of Randall [5], documenting that the dispar-
ity in receiving angiography was significant in the older
Aboriginal patients (aged 55–84 years) but not in younger
patients (aged 25–54 years), after adjusting for all other
measured confounders. These findings are consistent with
those of an Australian report which found that the largest
differences in receipt of angiography between Aboriginal
and non-Aboriginal IHD patients were among the 55–64
and 65–74 year age groups: in both, Aboriginal patients
were half as likely to receive the investigation, compared
with 90%, 70% and 60% for the 25–34, 35–44 and 45–54
year age groups respectively [32]. The disparity among
older Aboriginal patients in our study is less than that in
the report (13% vs 50% respectively) probably because in
the latter, receipt of angiography during a single admission
was determined from unlinked data, whereas we were able
to identify angiography in any admission during a 28-day
period. Furthermore, our study examined IHD events
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report included all IHD admissions, including elective ad-
missions in which clinician discretion and patient prefer-
ence may play a larger role. From administrative data, we
are unable to elucidate the reasons for the greater disparity
for Aboriginal patients in the older age group. In general,
elderly patients with MI are known to be managed more
conservatively than their younger counterparts, on the
basis of anticipated poorer outcomes partly attributable to
comorbidities, but the basis for this conservatism has been
questioned [33,34]. Eligibility for reperfusion declines with
age, and yet elderly patients are less likely to receive re-
perfusion even if eligible [35]. Explanations for the dispro-
portionate reduction in likelihood of angiography among
older Aboriginal patients could include confounding by
unmeasured clinical characteristics as well as clinicians’
‘therapeutic nihilism’ in relation to older Aboriginal pa-
tients or a higher level of patient refusal compared to
younger Aboriginal patients.
Regardless of age, the greatest contributors to the re-
duced likelihood of having an angiogram were comorbi-
dities, especially HF and kidney disease, and to a lesser
extent chronic pulmonary disease. HF and pre-existing
kidney disease, which are substantially over-represented in
Aboriginal patients, are important risk factors for contrast-
induced acute kidney injury in the setting of coronary
angiography [36] and hence the probability of having this
procedure is substantially lower amongst patients with
these comorbidities [3]. It remains to be determined if the
lower use of coronary angiography among patients with
these pre-existing comorbidities is attributable to phys-
ician reluctance to perform the procedure because of the
perceived risk [37], ‘therapeutic nihilism’ in relation to
such patients, or whether a different clinical presentation
of acute MI among such patients influences decision mak-
ing by physicians [36]. The decision to perform coronary
angiography in patients with these comorbid conditions
remains vexed: the poorer prognosis of IHD associated
with these comorbidities augments the anticipated abso-
lute benefit from definitive interventions (i.e. CARPs) [38]
yet angiographic contrast-induced acute kidney injury is
clearly associated with prolonged hospitalisation and an
increased likelihood of renal impairment, cardiovascular
events and death. However, mortality attributed to this ad-
verse reaction to contrast may have been widely over-
reported in unadjusted studies, being strongly confounded
by baseline clinical status [39].
The strength of this study was its use of person-linked
hospital and mortality data with state-wide coverage,
allowing us to follow patients throughout their 28-day
events. The use of 28-day events was based on previous
studies and ICD-10 coding standards [40-42]; repeating
the analysis for 90-day events produced similar results,
indicating that the relative risks are robust with respectto the definition of an event. Although Aboriginal status
is under-reported in administrative data, it is improving
[43]. Our sensitivity analyses with three methods of
Aboriginal identification produced similar results indi-
cating the findings are robust with respect to Aboriginal
identification. Similarly, our results were robust to previ-
ous events and receipt of coronary angiography in the
last year. Possible under-identification of comorbidities
did not influence our findings as the adjusted RRs for
Aboriginal status was similar with 1-, 2-, 5-, 10- and 15-
year look-back periods. However, there are limitations of
routinely collected administrative data. For example, de-
lineation of the reasons for the observed disparities is
limited by the absence of detailed data on clinical character-
isation of events (e.g. time-to-presentation, electrocardio-
graphic/biomarker findings) in relation to evidence-based
guidelines and standard practice for performing angiog-
raphy, as well as the absence of information on patient
preference in relation to invasive investigations. The use
of SEIFA scores as an ecological measure of SES ob-
scures heterogeneity of household SES status within a
collection district–many collection districts comprise
socio-economically disparate subgroups (notably including
Aboriginal people).
Conclusion
Evidence-based risk versus benefit considerations justify
a somewhat more conservative approach to acute IHD
in older patients, ramifying in a lower likelihood of re-
ceiving coronary angiography. However, departure from
clinical guidelines in actual practice resulting in under-
management of older patients is a well described prob-
lem [34,35]. The disproportionate under-management of
older Aboriginal IHD patients requires further explor-
ation through clinical and qualitative studies. Regardless
of age, much of the disparity experienced by metropol-
itan Aboriginal patients with IHD in receiving angiog-
raphy is accounted for by their high prevalence of
comorbidities. Our results echo those of the Australian
and New Zealand SNAPSHOT ACS study [28] in that
the burden of comorbidities accentuates the challenges
faced in applying evidence-based guidelines among pa-
tients in this context. The constellation of health prob-
lems interfacing with IHD (including chronic pulmonary
disease, diabetes, HF and kidney disease) accounts for
much of the disease burden and gap in life expectancy
encountered by Aboriginal people [44,45]. If, as sug-
gested by the results of the current study, the disparity
faced by metropolitan Aboriginal patients in receiving
coronary angiography for acute IHD is mediated sub-
stantially by comorbidities; the presence of these may be
considered a ‘double-whammy’ for Aboriginal Australians,
predisposing them to IHD while also adversely impact-
ing their receipt of coronary procedures. Our findings
Lopez et al. International Journal for Equity in Health 2014, 13:93 Page 11 of 12
http://www.equityhealthj.com/content/13/1/93of relatively modest disparities after adjustment for
measurable influences should not be interpreted as a
basis for complacency, but rather they highlight the
need for intensified preventative activity and improved
service delivery to Aboriginal people, addressing multi-
morbidity along with attention to the underlying social
determinants of health.
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